{"name":"Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.","slug":"laboratorios-de-biologicos-y-reactivos-de-m-xico-s-a-de-c-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Anti-scorpion venom serum Alacramyn","genericName":"Anti-scorpion venom serum Alacramyn","slug":"anti-scorpion-venom-serum-alacramyn","indication":"Scorpion envenomation (Centruroides species and related scorpion stings)","status":"phase_3"},{"name":"Anti-scorpion venom serum Birmex","genericName":"Anti-scorpion venom serum Birmex","slug":"anti-scorpion-venom-serum-birmex","indication":"Scorpion envenomation (treatment of systemic toxicity from scorpion stings)","status":"phase_3"},{"name":"Trivalent OPV Birmex","genericName":"Trivalent OPV Birmex","slug":"trivalent-opv-birmex","indication":"Prevention of poliomyelitis","status":"phase_3"},{"name":"Trivalent OPV Sanofi Pasteur","genericName":"Trivalent OPV Sanofi Pasteur","slug":"trivalent-opv-sanofi-pasteur","indication":"Prevention of poliomyelitis","status":"phase_3"},{"name":"serum antiscorpion","genericName":"serum antiscorpion","slug":"serum-antiscorpion","indication":"Scorpion envenomation (systemic toxicity)","status":"marketed"}]}],"pipeline":[{"name":"Anti-scorpion venom serum Alacramyn","genericName":"Anti-scorpion venom serum Alacramyn","slug":"anti-scorpion-venom-serum-alacramyn","phase":"phase_3","mechanism":"Alacramyn is an antivenom serum that neutralizes scorpion venom toxins through specific antibodies that bind to and inactivate venom components.","indications":["Scorpion envenomation (Centruroides species and related scorpion stings)"],"catalyst":""},{"name":"Anti-scorpion venom serum Birmex","genericName":"Anti-scorpion venom serum Birmex","slug":"anti-scorpion-venom-serum-birmex","phase":"phase_3","mechanism":"Anti-scorpion venom serum provides passive immunization by supplying antibodies that neutralize scorpion venom toxins.","indications":["Scorpion envenomation (treatment of systemic toxicity from scorpion stings)"],"catalyst":""},{"name":"Trivalent OPV Birmex","genericName":"Trivalent OPV Birmex","slug":"trivalent-opv-birmex","phase":"phase_3","mechanism":"Trivalent OPV Birmex is a vaccine that stimulates the body's immune response to protect against poliovirus.","indications":["Prevention of poliomyelitis"],"catalyst":""},{"name":"Trivalent OPV Sanofi Pasteur","genericName":"Trivalent OPV Sanofi Pasteur","slug":"trivalent-opv-sanofi-pasteur","phase":"phase_3","mechanism":"Trivalent OPV Sanofi Pasteur is a vaccine that stimulates the body's immune response to protect against poliovirus.","indications":["Prevention of poliomyelitis"],"catalyst":""},{"name":"serum antiscorpion","genericName":"serum antiscorpion","slug":"serum-antiscorpion","phase":"marketed","mechanism":"Serum antiscorpion is a polyclonal antivenom that neutralizes scorpion venom toxins through specific antibody binding.","indications":["Scorpion envenomation (systemic toxicity)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNMzhCZXp5WlVMOFhxVm01aVBpR0Q1VWh0ZUFhc1R4N2NNcjF5ekRXa1o3WHVKZ3pyTTZWeFJWUWN3QW1OY01CV1hYLW44X1UtZmNTQ0tCb0xIc2htRE02amUtSld2RGN0ZG14QldEeGFHOC1nS2dkcmJXNmVZUG1DSFZnZDRMOHBCQTJ1S2t5ZFhTUVNySWRES0JMTHMwU3BkNVp1X2dMcWxVcUdYYTZEanRPZ2d5QVhZTHYtSjRMWEVFUktzY2h5OFF1UDZjOHdqT014V3pNYWhveHE5MU5aTXVLWTk2bEFySG5R?oc=5","date":"2024-12-12","type":"pipeline","source":"insightplus.bakermckenzie.com","summary":"Mexico: New Rules for the consolidated purchase of drugs and medical devices for 2025-2026 - insightplus.bakermckenzie.com","headline":"Mexico: New Rules for the consolidated purchase of drugs and medical devices for 2025-2026","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":4,"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}